GoodRx Holdings, Inc. (GDRX) vs Nektar Therapeutics (NKTR)
A side-by-side comparison of GoodRx Holdings, Inc. and Nektar Therapeutics across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GDRX
GoodRx Holdings, Inc.
$3.33HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
NKTR
Nektar Therapeutics
$40.68HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
Total return — GDRX vs NKTR
growth of $100 · dividends reinvested · last 6yGDRX -93.3% (-36.3%/yr)NKTR -85.7% (-27.7%/yr)NKTR compounded faster over this window
GDRX NKTR
GDRX vs NKTR: by the numbers
- •NKTR is the larger company ($1.17B vs $1.15B market cap).
- •GDRX is profitable (2.07% net margin) while NKTR runs a net loss (-287.84%).
- •GDRX grew revenue faster over the past five years (4.47% vs -12.34% CAGR).
Metrics side by side
Valuation
| Metric | GDRX | NKTR |
|---|---|---|
| P/E ratio | 78.24 | N/A |
| P/S ratio | 1.47 | 21.38 |
| P/B ratio | 1.78 | 1.29 |
| EV / EBITDA | 8.25 | N/A |
| FCF yield | 12.65% | N/A |
Profitability
| Metric | GDRX | NKTR |
|---|---|---|
| Gross margin | 88.05% | 99.36% |
| Operating margin | 10.25% | -240.38% |
| Net margin | 2.07% | -287.84% |
| ROE | 2.51% | -17.40% |
| ROIC | 3.72% | -12.53% |
Growth (annualized)
| Metric | GDRX | NKTR |
|---|---|---|
| Revenue CAGR (5Y) | 4.47% | -12.34% |
| FCF CAGR (5Y) | 11.72% | N/A |
| Total return CAGR (5Y) | -39.98% | -30.33% |
Frequently asked
- Which has grown faster, GDRX or NKTR?
- Over the past five years, GDRX grew revenue faster — GDRX at a 4.47% CAGR versus NKTR at -12.34%.
- Is GDRX or NKTR more profitable?
- GDRX runs the higher net margin — GDRX at 2.07% versus NKTR at -287.84%.
- How have GDRX and NKTR total returns compared?
- Over the past 5 years, GDRX delivered -39.98% and NKTR delivered -30.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
GoodRx P/E ratioGoodRx ROENektar Therapeutics ROEGoodRx operating marginNektar Therapeutics operating marginGoodRx revenue growthNektar Therapeutics revenue growthGoodRx free cash flowNektar Therapeutics free cash flow
GoodRx & Nektar Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.